LeanBio Therapeutics, Inc. funding
LeanBio Therapeutics, Inc., a biotechnology company based in Brookline, MA (founded 2026), filed a Form D with the SEC on October 22, 2026 and reported a open-ended offering with no sales yet.
Amount raisedNot yet sold
Offering sizeOpen-ended
Filed with the SECOctober 22, 2026
First saleYet to occur
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationBrookline, MA
Founded2026
Entity typeCorporation
Investors so far0
Minimum investment—
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 22
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$16.3M · Oct 23Other Health CareCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health CareBridgeHealth Pharmaceuticals, Inc.$3.5M · Nov 5PharmaceuticalsQuiver Holdings Inc.$3M · Oct 21Biotechnology